114 related articles for article (PubMed ID: 36111755)
1. Identification of 5F-Cumyl-PINACA, a Synthetic Cannabinoid, in the Herbal Material Used for Recreational Purposes in the Province of Trieste: Public Health Implications.
Peruch M; Addobbati R; Padovano M; Scopetti M; Concato M; Radaelli D; D'Errico S
Curr Pharm Biotechnol; 2023 Apr; 24(6):758-765. PubMed ID: 36111755
[TBL] [Abstract][Full Text] [Related]
2. 5F-Cumyl-PINACA in 'e-liquids' for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACA.
Angerer V; Franz F; Moosmann B; Bisel P; Auwärter V
Forensic Toxicol; 2019; 37(1):186-196. PubMed ID: 30636986
[TBL] [Abstract][Full Text] [Related]
3. Structural characterization of the new synthetic cannabinoids CUMYL-PINACA, 5F-CUMYL-PINACA, CUMYL-4CN-BINACA, 5F-CUMYL-P7AICA and CUMYL-4CN-B7AICA.
Bovens M; Bissig C; Staeheli SN; Poetzsch M; Pfeiffer B; Kraemer T
Forensic Sci Int; 2017 Dec; 281():98-105. PubMed ID: 29125990
[TBL] [Abstract][Full Text] [Related]
4. Metabolism studies of 4'Cl-CUMYL-PINACA, 4'F-CUMYL-5F-PINACA and 4'F-CUMYL-5F-PICA using human hepatocytes and LC-QTOF-MS analysis.
Stalberga D; Ingvarsson S; Bessa G; Maas L; Vikingsson S; Persson M; Norman C; Gréen H
Basic Clin Pharmacol Toxicol; 2023 Mar; 132(3):263-280. PubMed ID: 36544361
[TBL] [Abstract][Full Text] [Related]
5. Profiling of synthesis-related impurities of the synthetic cannabinoid Cumyl-5F-PINACA in seized samples of e-liquids via multivariate analysis of UHPLC-MS
Münster-Müller S; Matzenbach I; Knepper T; Zimmermann R; Pütz M
Drug Test Anal; 2020 Jan; 12(1):119-126. PubMed ID: 31307120
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA.
Banister SD; Adams A; Kevin RC; Macdonald C; Glass M; Boyd R; Connor M; McGregor IS; Havel CM; Bright SJ; Vilamala MV; Lladanosa CG; Barratt MJ; Gerona RR
Drug Test Anal; 2019 Feb; 11(2):279-291. PubMed ID: 30151911
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of Cumyl-Carboxamide Synthetic Cannabinoid New Psychoactive Substances (NPS) CUMYL-BICA, CUMYL-PICA, CUMYL-5F-PICA, CUMYL-5F-PINACA, and Their Analogues.
Longworth M; Banister SD; Boyd R; Kevin RC; Connor M; McGregor IS; Kassiou M
ACS Chem Neurosci; 2017 Oct; 8(10):2159-2167. PubMed ID: 28792725
[TBL] [Abstract][Full Text] [Related]
8. In vitro metabolism of the synthetic cannabinoids CUMYL-PINACA, 5F-CUMYL-PINACA, CUMYL-4CN-BINACA, 5F-CUMYL-P7AICA and CUMYL-4CN-B7AICA.
Staeheli SN; Poetzsch M; Veloso VP; Bovens M; Bissig C; Steuer AE; Kraemer T
Drug Test Anal; 2018 Jan; 10(1):148-157. PubMed ID: 28885775
[TBL] [Abstract][Full Text] [Related]
9. Occupational transdermal poisoning with synthetic cannabinoid cumyl-PINACA.
Dobaja M; Grenc D; Kozelj G; Brvar M
Clin Toxicol (Phila); 2017 Mar; 55(3):193-195. PubMed ID: 28084855
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and
Cannaert A; Sparkes E; Pike E; Luo JL; Fang A; Kevin RC; Ellison R; Gerona R; Banister SD; Stove CP
ACS Chem Neurosci; 2020 Dec; 11(24):4434-4446. PubMed ID: 33253529
[TBL] [Abstract][Full Text] [Related]
11. Distinguishing Intake of New Synthetic Cannabinoids ADB-PINACA and 5F-ADB-PINACA with Human Hepatocyte Metabolites and High-Resolution Mass Spectrometry.
Carlier J; Diao X; Scheidweiler KB; Huestis MA
Clin Chem; 2017 May; 63(5):1008-1021. PubMed ID: 28302730
[TBL] [Abstract][Full Text] [Related]
12. Identification of synthetic cannabinoids that were seized, consumed, or associated with deaths in Kuwait in 2018 using GC-MS and LC-MS-MS analysis.
Al-Matrouk A; Alqallaf M; AlShemmeri A; BoJbarah H
Forensic Sci Int; 2019 Oct; 303():109960. PubMed ID: 31550599
[TBL] [Abstract][Full Text] [Related]
13. Using in vitro receptor activity studies of synthetic cannabinoids to support the risk assessment of new psychoactive substances - A Swedish strategy to protect public health from harm.
Bäckberg M; Vikingsson S; Strandberg J; Wall S; Åstrand A; Karlsson H; Persson M; Kronstrand R; Green H
Forensic Sci Int; 2023 Jul; 348():111691. PubMed ID: 37116244
[TBL] [Abstract][Full Text] [Related]
14. GC-MS Identification and Quantification of the Synthetic Cannabinoid MDMB-4en- PINACA in Cannabis-derived Material Seized in the Turin Metropolitan Area (Italy).
Gerace E; Seganti F; Di Corcia D; Vincenti M; Salomone A
Curr Pharm Des; 2022; 28(32):2618-2621. PubMed ID: 35658890
[TBL] [Abstract][Full Text] [Related]
15. Identification and analytical characterization of six synthetic cannabinoids NNL-3, 5F-NPB-22-7N, 5F-AKB-48-7N, 5F-EDMB-PINACA, EMB-FUBINACA, and EG-018.
Liu C; Jia W; Hua Z; Qian Z
Drug Test Anal; 2017 Aug; 9(8):1251-1261. PubMed ID: 28063270
[TBL] [Abstract][Full Text] [Related]
16. Cardiac effects of 5F-Cumyl-PEGACLONE.
Esdar N; Pawlik E; Eickhoff SB; Raupach A; Ritz-Timme S; Mayer F
Int J Legal Med; 2024 May; 138(3):823-831. PubMed ID: 38214738
[TBL] [Abstract][Full Text] [Related]
17. Fatal intoxication by 5F-ADB and diphenidine: Detection, quantification, and investigation of their main metabolic pathways in humans by LC/MS/MS and LC/Q-TOFMS.
Kusano M; Zaitsu K; Taki K; Hisatsune K; Nakajima J; Moriyasu T; Asano T; Hayashi Y; Tsuchihashi H; Ishii A
Drug Test Anal; 2018 Feb; 10(2):284-293. PubMed ID: 28544560
[TBL] [Abstract][Full Text] [Related]
18. Human phase-I metabolism and prevalence of two synthetic cannabinoids bearing an ethyl ester moiety: 5F-EDMB-PICA and EDMB-PINACA.
Giorgetti A; Brunetti P; Haschimi B; Busardò FP; Pelotti S; Auwärter V
Drug Test Anal; 2023 Mar; 15(3):299-313. PubMed ID: 36366743
[TBL] [Abstract][Full Text] [Related]
19. Identification and quantification of synthetic cannabinoids in 'spice-like' herbal mixtures: Update of the German situation in summer 2018.
Ernst L; Langer N; Bockelmann A; Salkhordeh E; Beuerle T
Forensic Sci Int; 2019 Jan; 294():96-102. PubMed ID: 30497049
[TBL] [Abstract][Full Text] [Related]
20. New synthetic cannabinoids carrying a cyclobutyl methyl side chain: Human Phase I metabolism and data on human cannabinoid receptor 1 binding and activation of Cumyl-CBMICA and Cumyl-CBMINACA.
Haschimi B; Grafinger KE; Pulver B; Psychou E; Halter S; Huppertz LM; Westphal F; Pütz M; Auwärter V
Drug Test Anal; 2021 Aug; 13(8):1499-1515. PubMed ID: 33788409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
